Regenerative medicine company InGeneron has appointed Angelo Moesslang CEO. Before joining Houston-based InGeneron, Moesslang was CFO of Fresenius Medical Care North America, part of German company Fresenius Medical Care. Earlier this year, InGeneron raised $20 million to support clinical testing of a stem cell-based system meant to aid recovery from wounds and orthopedic injuries.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
